Abbvie Inc - ESG Rating & Company Profile powered by AI
The page displays a free E,S&G report covering Abbvie Inc. The ESG rating includes 17 UN SDGs including: 'Gender Equality', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'. If you are employed by Abbvie Inc and you wish to use your ESG rating, please get in touch.
Abbvie Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.3; made up of an environmental score of 7.0, social score of 7.0 and governance score of 8.0.
7.3
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 160 | YungShin Global Holding Corp | 7.5 | High |
| 160 | Zentiva SA | 7.5 | High |
| 191 | Abbvie Inc | 7.3 | High |
| 191 | Cellectis SA | 7.3 | High |
| 191 | Aurinia Pharmaceuticals Inc | 7.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Abbvie Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Abbvie Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Abbvie Inc report the average age of the workforce?
Sign up for free to unlockDoes Abbvie Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Abbvie Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Abbvie Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Abbvie Inc offer flexible work?
Sign up for free to unlockDoes Abbvie Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Abbvie Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Abbvie Inc conduct supply chain audits?
Sign up for free to unlockDoes Abbvie Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Abbvie Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Abbvie Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Abbvie Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Abbvie Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Abbvie Inc disclose water use targets?
Sign up for free to unlockDoes Abbvie Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Abbvie Inc have a product recall in the last two years?
Sign up for free to unlockDoes Abbvie Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Abbvie Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Abbvie Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Abbvie Inc disclose parental leave metrics?
Sign up for free to unlockDoes Abbvie Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Abbvie Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Abbvie Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Abbvie Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Abbvie Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Abbvie Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Abbvie Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Abbvie Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Abbvie Inc disclose its waste policy?
Sign up for free to unlockDoes Abbvie Inc report according to TCFD requirements?
Sign up for free to unlockDoes Abbvie Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Abbvie Inc disclose energy use targets?
Sign up for free to unlockDoes Abbvie Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Abbvie Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Abbvie Inc
These potential risks are based on the size, segment and geographies of the company.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.